Lilly - NUS (Singapore)
 Lilly: Answers That Matter.
homeabout usresearch interestscareersvolunteerscontact us
Lilly - NUS Research Interests


Overview  |  Endocrine Disorders  |  Infectious Diseases  |  Neuroscience  |  Cardiovascular Diseases  |  Drug Metabolism / Miscellaneous

Infectious Diseases

  1. Clinical Evaluation of Dose Response to Anti-Hepatitis B Therapy Using Viral Dynamic Modeling. Digestive Disease Week - San Francisco - 19 to 22 May 2002

  2. Fatty Liver (FL) in Chronic Hepatitis B Carriers may affect the interpretation of Alanine Aminotransferable (ALT) Elevations. 37th Annual Meeting of the European Association for the Study of the Liver. Madrid (Spain) - 15 to 21 April 2002.

  3. Potent Antiviral Activity of LY582563 (MCC-478) in Chronic Hepatitis B Infected Patients. 37th Annual Meeting of the European Association for the Study of the Liver. Madrid (Spain) - 15 to 21 April 2002.

  4. Safety and Pharmacokinetics of a Novel Nucleotide Analogue, MCC-478 (LY582563) for Treatment of Hepatitis B. Hep Dart 2001, Maui, Hawaii - 16 to 20 December 2001.

We'd like to tell you more about our company and the work we do.
 
Copyright © 2005 Eli Lilly and Company. All rights reserved.       Site Map